![Timothy Mayer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Mayer
Chief Operating Officer at
NEXTCURE, INC.
Net worth: 3 230 $ as of 2026-06-29
Profile
Dr. Timothy Mayer is a Chief Operating Officer at NextCure, Inc. Dr. Mayer was previously employed as a Senior Director-Intellectual Property by MacroGenics, Inc. He received his undergraduate degree from California Polytechnic State University (San Luis Obispo) and a doctorate degree from Pennsylvania State University College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXTCURE, INC. 0.08% | 2026-04-21 | 2,019 ( 0.08% ) | 3 230 $ | 2026-06-29 |
Timothy Mayer active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Chief Operating Officer | 2019-10-01 |
Former positions of Timothy Mayer
| Companies | Position | End |
|---|---|---|
| MACROGENICS, INC. | Corporate Officer/Principal | 2016-01-31 |
Training of Timothy Mayer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
28
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
California Polytechnic State University (San Luis Obispo)
 California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pennsylvania State University College of Medicine
 Pennsylvania State University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
- Stock Market
- Insiders
- Timothy Mayer
